Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Equity Consolidated Statement of Equity

v3.7.0.1
Consolidated Statement of Equity Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Directors
Common Stock [Member]
Employees
Common Stock [Member]
Executive Officers
Common Stock [Member]
Common stock, shares outstanding, beginning of period at Mar. 31, 2014   31,920,865            
Balance, beginning of period at Mar. 31, 2014 $ 250,466 $ 208,483 $ 49,863 $ 0 $ (7,880)      
Issuance of common stock in exercise of stock options, shares 46,623 88,050            
Issuance of common stock in exercise of stock options $ 547 $ 547            
Issuance of restricted stock as deferred compensation to employees and directors           11,956    
Issuance of common stock in lieu of compensation, shares             46,360 15,162
Stock-based compensation expense   3,295            
Excess tax deduction from stock options 1,592 $ 1,592            
Net income (loss) 49,386   49,386          
Foreign curency translation adjustment (32,667)       (32,667)      
Interest rate swap (404)       (404)      
Other (449)       (449)      
Income attributable to non-controlling interests 0              
Common stock, shares outstanding, end of period at Mar. 31, 2015   32,082,393.000            
Balance, end of period at Mar. 31, 2015 271,766 $ 213,917 99,249 0 (41,400)      
Issuance of common stock in exercise of stock options, shares   29,056            
Issuance of common stock in exercise of stock options $ 240 $ 240            
Issuance of restricted stock as deferred compensation to employees and directors 18,578         18,578    
Issuance of common stock in lieu of compensation, shares             69,704 22,989
Stock-based compensation expense $ 3,749 3,749            
Excess tax deduction from stock options 92 92            
Repurchase of employee stock units on vesting (1,265) $ (1,265)            
Net income (loss) 23,009   23,009          
Foreign curency translation adjustment (3,242)       (3,242)      
Interest rate swap (340)       (340)      
Other 413       413      
Non-controlling interest in acquisition 3,638     3,638        
Income attributable to non-controlling interests $ (641)     (641)        
Common stock, shares outstanding, end of period at Mar. 31, 2016 32,222,270 32,222,720.00            
Balance, end of period at Mar. 31, 2016 $ 298,701 $ 216,733 122,258 4,279 (44,569)      
Issuance of common stock in exercise of stock options, shares   43,121            
Issuance of common stock in exercise of stock options 250 $ 250            
Issuance of restricted stock as deferred compensation to employees and directors   19,824       19,824    
Issuance of common stock in lieu of compensation, shares             47,179 32,709
Stock-based compensation expense 3,402 $ 3,402            
Excess tax deduction from stock options (1,069) $ (1,069)            
Net income (loss) 14,641   14,641          
Foreign curency translation adjustment (4,536)       (4,536)      
Interest rate swap 791       791      
Other (21)       (21)      
Income attributable to non-controlling interests $ (343)     (343)        
Common stock, shares outstanding, end of period at Mar. 31, 2017 32,365,553 32,365,553.000            
Balance, end of period at Mar. 31, 2017 $ 312,502 $ 219,316 $ 136,899 $ 4,622 $ (48,335)